Skip to main content
. 2023 Feb 22;8(4):e156643. doi: 10.1172/jci.insight.156643

Figure 2. Evidence for association with ADA development (–log10 P value) from a genome-wide analysis of 10,917,604 genetic variants (discovery cohort: individuals sampled 6–36 months after treatment initiation, n = 784).

Figure 2

Chromosomes shown in alternating shading; red line indicates the threshold for genome-wide significance (P = 5 × 10–8). Logistic regression was used.